ストックスクリーナーアプリを入手
517.46
0.47%
3.115
前日終値:
$514.34
開ける：
$514.35
24時間の取引高:
144.86K
Relative Volume:
0.08
時価総額：
$196.14B
収益：
$42.88B
当期純損益:
$6.34B
株価収益率:
31.30
EPS:
16.53
ネットキャッシュフロー:
$7.27B
1週間 パフォーマンス:
-0.32%
1か月 パフォーマンス:
-3.10%
6か月 パフォーマンス:
-16.56%
1年 パフォーマンス:
-9.16%
1日の値動き範囲:
$512.20
$517.12
1週間の範囲:
$510.00
$526.80
52週間の値動き範囲:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
516.95 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
213.16 | 152.09B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
419.64 | 34.45B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
120.56 | 34.37B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
180.78 | 32.81B | 15.41B | 1.37B | 2.11B | 7.50 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Flow Cytometry Market Is Booming Worldwide | Luminex - openPR
Is Thermo Fisher Scientific Inc. (TMO) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey
Thermo Fisher takes No. 1 spot on WNY life science list for first time - The Business Journals
High Content Screening/Imaging Market Analysis 2025-2029: Increasing R&D Budgets, Emerging Economies and Technological Advances Fueling Opportunities - GlobeNewswire Inc.
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab To Transform Semiconductor Analysis - Technology Networks
Is Thermo Fisher Scientific Inc. (TMO) The Best Healthcare Dividend Stock to Invest in? - MSN
Cell Line Development Market is Expected to Grow at a CAGR - openPR
Thermo Fisher Scientific Introduces the Vulcan™ Automated Lab to Transform Semiconductor Analysis - MSN
Precision Oncology Market Top Companies StudyThermo Fisher - openPR
Gamma Ray Spectroscopy Market Is Booming Worldwide 2025-2032 | - openPR
Thermo Fisher Scientific (TMO) Fell as Expectations for Demand Recovery in 2025 Continue to Moderate - MSN
Genetic Toxicology Testing Market Is Booming Worldwide | Thermo - openPR
Life Science Instrumentation Market Demand, Growth and Future - openPR
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab - Yahoo Finance
GMP Cell Therapy Consumables Market Deep Research 2025-2032 | - openPR
South East Asia And South Asia Industrial Microbiology Market - openPR
Proteinase K Market Future Business Opportunities 2025-2032 | Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V. - openPR
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga
Thermo Fisher Scientific Thrives Amid Diabetes Market Expansion - Zenopa
Bioreactors Market to Witness Remarkable Growth with Thermo Fisher Scientific, Inc., Merck KGaA - openPR
Pharmacogenomics Market Growth and Future Scope 2025-2032 | - openPR
Thermo Fisher Scientific's $4B Filtration Acquisition & - openPR
The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP - Yahoo Finance
DNA Sequencing Market Detailed In New Research Report 2025 | - openPR
Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific - MSN
Thermo Fisher Scientific (TMO): One of the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey
Thermo Fisher Scientific (NYSE:TMO) Advances Semiconductor Manufacturing With New Automated Lab Solution - Yahoo Finance
Biomedical Refrigerators Market to Witness Remarkable Growth with Thermo Fisher Scientific, Aegis Scientific, Inc. - openPR
Helicobacter Pylori Diagnostic Market Top Companies Study - openPR
Is Thermo Fisher Scientific Inc. (TMO) the Best Strong Buy Stock to Buy Right Now? - Insider Monkey
Biotechnology Reagents and Kits Market A Comprehensive Study - openPR
Gas Chromatography Market Is Booming Worldwide 2025-2032 | - openPR
Thermo Fisher Scientific debuts Transcend VTLX-1 UHPLC system for automated sample preparation - R&D World
$100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth This Much Today - Benzinga
Is the Market Bullish or Bearish on Thermo Fisher Scientific? - Benzinga
Senior VP & General Counsel Michael Boxer Sold A Bunch Of Shares In Thermo Fisher Scientific - Simply Wall St
HSBC Adjusts Price Target on Thermo Fisher Scientific to $670 From $700, Keeps Buy Rating - Marketscreener.com
Faces of HR: Thermo Fisher Scientific's Pallavi Srivastava on the importance of fungibility of skills within the workforce - Human Resources Online
New exhibit at Discovery Center showcases lab techniques for kids - MyStateline.com
Market Whales and Their Recent Bets on TMO Options - Benzinga
CRDMO Market Research 2025: A Highly Competitive $328 - GlobeNewswire
Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR
Thermo Fisher Scientific’s CHF1.425 Billion Bond Issuance - Global Legal Chronicle
Laboratory Equipment and Disposables Market is expected - openPR
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
Ex-Dividend Reminder: Gilead Sciences, CONMED and Thermo Fisher Scientific - Nasdaq
Thermo Fisher Executive Cashes In on Stock Sale! - TipRanks
Thermo Fisher Scientific SVP sells $2.01 million in stock By Investing.com - Investing.com Australia
Thermo Fisher Scientific SVP sells $2.01 million in stock - Investing.com
Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire
Neurological Biomarkers: Global Market Review 2020-2024 and Forecast to 2030, Featuring Analysis of PerkinElmer, Abbott Labs, Thermo Fisher Scientific, Banyan Biomarkers, Bio-Rad Labs & More - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
0.02%
大文字化:
|
ボリューム (24 時間):